KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

AbCellera Biologics (ABCL) Shares Outstanding (2020 - 2025)

AbCellera Biologics' Shares Outstanding history spans 6 years, with the latest figure at $299.0 million for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding rose 1.31% year-over-year to $299.0 million, compared with a TTM value of $299.0 million through Sep 2025, up 1.31%, and an annual FY2019 reading of $151.7 million, changed N/A over the prior year.
  • Shares Outstanding for Q3 2025 was $299.0 million at AbCellera Biologics, roughly flat from $298.7 million in the prior quarter.
  • The five-year high for Shares Outstanding was $299.0 million in Q3 2025, with the low at $270.9 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $288.8 million, with a median of $289.2 million recorded in 2023.
  • Year-over-year, Shares Outstanding surged 13254.71% in 2021 and then grew 1.31% in 2025.
  • Tracing ABCL's Shares Outstanding over 5 years: stood at $281.2 million in 2021, then grew by 1.64% to $285.8 million in 2022, then increased by 1.41% to $289.8 million in 2023, then rose by 1.86% to $295.2 million in 2024, then increased by 1.31% to $299.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABCL's Shares Outstanding are $299.0 million (Q3 2025), $298.7 million (Q2 2025), and $298.4 million (Q1 2025).